SOPHiA GENETICS™ Myeloid Solution

Characterize key biomarkers with our comprehensive research application covering 30 genes associated with myelo- dysplastic syndromes, myeloproliferative neoplasms, and leukemia. This all-in-one solution enables assessment of DNA alterations aligned with key guidelines, including challenging genes (CALR, CEBPA, ASXL1, FLT3, including internal tandem duplications).

Want to learn more?

One of our experts will be in touch with you shortly!

First Name

Last Name

Institution

Job Title

Phone

Country

Comments

Privacy Policy I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. View our Privacy Policy for more information.

Pardot Opt-in I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able to unsubscribe by using the link integrated with the communication at any time.

Comments

Enabling precise characterization of blood cancer driver genes by targeting relevant DNA variants and RNA fusion genes from blood or bone marrow samples.